Intuitive Surgical, Inc. ISRG

405.18 5.66 1.42% as of 25 Sep
Market cap
$140.7B
P/E
45.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Revenue
2,706.50 3,138.20 3,724.20 4,478.50 4,358.40 5,710.10 6,222.20 7,124.10 8,352.10 10,064.70
Revenue Growth
13.51% 15.95% 18.67% 20.25% (2.68%) 31.01% 8.97% 14.49% 17.24% 20.51%
Cost of Revenue
813.60 936.20 1,120.10 1,368.30 1,497.20 1,751.60 2,026.20 2,394.60 2,717.90 3,422.40
Gross Profit
1,892.90 2,202.00 2,604.10 3,110.20 2,861.20 3,958.50 4,196.00 4,729.50 5,634.20 6,642.30
R&D Expenses
239.60 328.60 418.10 557.30 595.10 671.00 879.00 998.80 1,145.30 1,311.80
SG&A Expenses
703.60 810.50 986.60 1,178.40 1,216.30 1,466.50 1,739.90 1,963.90 2,140.00 2,385.00
Operating Income
949.70 1,062.90 1,199.40 1,374.50 1,049.80 1,821.00 1,577.10 1,766.80 2,348.90 2,945.50
Non-operating Income/Expense
35.60 41.90 80.10 127.70 157.20 69.30 29.70 192.10 324.90 365.90
EBT
985.30 1,104.80 1,279.50 1,502.20 1,207.00 1,890.30 1,606.80 1,958.90 2,673.80 3,311.40
Income Tax Provision
247.00 433.90 154.50 120.40 140.20 162.20 262.40 141.60 336.30 434.80
Income after Tax
738.30 670.90 1,125.00 1,381.80 1,066.80 1,728.10 1,344.40 1,817.30 2,337.50 2,876.60
Dividends (Preferred)
— — — — 0.00 — — — — —
Non-Controlling Interest
— — (2.90) 2.50 6.20 23.50 22.10 19.30 14.90 20.60
Net Income Common
738.30 670.90 1,127.90 1,379.30 1,060.60 1,704.60 1,322.30 1,798.00 2,322.60 2,856.00
EPS (Basic)
2.13 1.97 3.31 3.98 3.02 4.79 3.72 5.12 6.54 8.00
EPS (Diluted)
2.08 1.89 3.16 3.85 2.94 4.66 3.65 5.03 6.42 7.87
Shares (Basic, Weighted)
344.70 335.10 341.10 346.20 351.10 356.10 355.70 351.20 355.20 356.90
Shares (Diluted, Weighted)
353.70 348.90 356.40 358.40 361.00 365.80 362.00 357.40 362.00 362.70
Gross Margin
69.94% 70.17% 69.92% 69.45% 65.65% 69.32% 67.44% 66.39% 67.46% 66.00%
EBIT Margin
35.09% 33.87% 32.21% 30.69% 24.09% 31.89% 25.35% 24.80% 28.12% 29.27%
EBT margin
36.40% 35.20% 34.36% 33.54% 27.69% 33.10% 25.82% 27.50% 32.01% 32.90%
Net Profit Margin
27.28% 21.38% 30.29% 30.80% 24.33% 29.85% 21.25% 25.24% 27.81% 28.38%
Free Cash Flow Margin
38.17% 30.37% 26.37% 26.18% 26.23% 30.65% 15.40% 10.52% 15.61% 24.75%
EBITDA
1,051.90 1,172.90 1,332.80 1,590.60 1,343.10 2,163.80 1,969.50 2,221.60 2,848.60 3,622.60
EBIT
949.70 1,062.90 1,199.40 1,374.50 1,049.80 1,821.00 1,577.10 1,766.80 2,348.90 2,945.50
Income from Continuous Operations
738.30 670.90 1,125.00 1,381.80 1,066.80 1,728.10 1,344.40 1,817.30 2,337.50 2,876.60
Consolidated Net Income/Loss
738.30 670.90 1,125.00 1,381.80 1,066.80 1,728.10 1,344.40 1,817.30 2,337.50 2,876.60
EPS (Basic, from Continuous Ops)
2.14 2.00 3.30 3.99 3.04 4.85 3.78 5.17 6.58 8.06
EPS (Basic, Consolidated)
2.14 2.00 3.30 3.99 3.04 4.85 3.78 5.17 6.58 8.06
EPS (Diluted, from Cont. Ops)
2.09 1.92 3.16 3.86 2.96 4.72 3.71 5.08 6.46 7.93
Shares (Diluted, Average)
353.70 348.90 356.40 358.50 360.90 365.80 362.00 357.40 362.00 362.70
EPS (Diluted, Consolidated)
2.09 1.92 3.16 3.86 2.96 4.72 3.71 5.08 6.46 7.93
EBITDA Margin
38.87% 37.37% 35.79% 35.52% 30.82% 37.89% 31.65% 31.18% 34.11% 35.99%
Operating Cash Flow Margin
40.16% 36.45% 31.41% 35.69% 34.07% 36.59% 23.96% 25.46% 28.91% 30.11%

Fold the line items

In millions of $ except per-share values · columns are period end dates